These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16867918)

  • 1. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone.
    Sergio F; Maria Clara D; Gabriella F; Giorgia S; Sara De Carolis ; Giancarlo P; Alessandro C
    Hypertens Pregnancy; 2006; 25(2):115-27. PubMed ID: 16867918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy.
    Urban G; Vergani P; Tironi R; Ceruti P; Vertemati E; Sala F; Pogliani E; Triche EW; Lockwood CJ; Paidas MJ
    Int J Fertil Womens Med; 2007; 52(2-3):59-67. PubMed ID: 18320863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
    Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
    Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antithrombotic therapy on the recurrence of placenta-mediated diseases in pregnancy.
    Neykova K; Dimitrova V; Dimitrov R
    J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1462-1468. PubMed ID: 32403962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [INDICATIONS FOR ANTITHROMBOTIC MEDICATION DURING PREGNANCY--ANALYSIS OF CURRENT PRACTICES IN BULGARIA].
    Neikova K ; Dimitrova V; Dimitrov R; Savov A
    Akush Ginekol (Sofiia); 2015; 54(5):3-12. PubMed ID: 26411189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
    Lefkou E; Varoudi K; Pombo J; Jurisic A; Jurisic Z; Contento G; Girardi G
    Biochem Pharmacol; 2020 Dec; 182():114217. PubMed ID: 32926874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage.
    Elmahashi MO; Elbareg AM; Essadi FM; Ashur BM; Adam I
    BMC Res Notes; 2014 Jan; 7():23. PubMed ID: 24405979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
    Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
    Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
    Chen J; Huai J; Yang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-molecular-weight heparin and aspirin in recurrent pre-eclampsia: A stratified cohort study.
    Zhang Y; Shen F; Yang W; Wang J; Zhou J; Chen Y
    Int J Gynaecol Obstet; 2021 Aug; 154(2):337-342. PubMed ID: 33314052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
    Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anticoagulant therapy on pregnancy outcomes in patients with thrombophilia and previous poor obstetric history.
    Mutlu I; Mutlu MF; Biri A; Bulut B; Erdem M; Erdem A
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):267-73. PubMed ID: 25268607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ANTITHROMBOTIC MEDICATION IN PREGNANT WOMEN WITH PREVIOUS INTRAUTERINE GROWTH RESTRICTION].
    Neykova K; Dimitrova V; Dimitrov R; Vakrilova L
    Akush Ginekol (Sofiia); 2016; 55(2):3-9. PubMed ID: 27509650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study.
    Fischer-Betz R; Specker C; Brinks R; Schneider M
    Lupus; 2012 Oct; 21(11):1183-9. PubMed ID: 22685017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjusted prophylactic doses of nadroparin plus low dose aspirin therapy in obstetric antiphospholipid syndrome. A prospective cohort management study.
    Ruffatti A; Gervasi MT; Favaro M; Ruffatti AT; Hoxha A; Punzi L
    Clin Exp Rheumatol; 2011; 29(3):551-4. PubMed ID: 21640048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pravastatin is useful for prevention of recurrent severe placenta-mediated complications - a pilot study.
    Kupferminc MJ; Kliger C; Rimon E; Asher-Landsberg J; Skornick-Rapaport A; Gamzu R; Yogev Y
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8055-8061. PubMed ID: 34154497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy.
    Alguel G; Vormittag R; Simanek R; Kyrle PA; Quehenberger P; Mannhalter C; Husslein P; Pabinger I
    Thromb Haemost; 2006 Sep; 96(3):285-9. PubMed ID: 16953268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.